FindTrial
Sign In

Study of Pipaladi leha in Tamak Shwasa (Bronchial asthama)

Clinical evaluation of Pipaladi Leh in Tamak Shwasa

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043739
Enrollment
50
Registered
2022-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Sponsors

Uttarakhand Ayurveda University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children diagnosed as the case of Tamak Shwasa with the presenting symptoms. 2. Mild and moderate asthama according to Global Initiative for Asthama (GINA) guidelines.

Exclusion criteria

Exclusion criteria: 1. Below the age of 6years and above the age of 14 years. 2. severe Asthama according to the Global Initiative for Asthama (GINA) guidelines.

Design outcomes

Secondary

MeasureTime frame
1. Exacerbation in sign and symptoms 2. Improvement in Peak Expiratory Flow RateTimepoint: It will be assessed every 2nd week for 2 months—

Primary

MeasureTime frame
it will be assessed based on following parameters- 1. Relief in difficulty in breathing 2. Relief in intensity of cough 3. Relief in Rhinitis intensity 4. improvement in Disturbed sleep 5. Relief in frequency of Shwasa VegaTimepoint: It will be assessed every 2nd week for 2 months—

Countries

India

Contacts

Public ContactDr Mohar

Rishikul Campus Uttarakhand Ayurveda University Haridwar

anupgakkhar@yahoo.com9410982602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026